Free tool
FAERS Monitor: Sodium Chloride 0.9% and Potassium Chloride 0.075%
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017648 or its brand name (Sodium Chloride 0.9% and Potassium Chloride 0.075%, Potassium Chloride, Sodium Chloride). Reports on generic versions are filed under their own applications.
Reports
60
Serious
44
73% of reports
Hospitalization
34
Death reported
10
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- hypokalaemia10
- acute kidney injury9
- dehydration7
- crohn^s disease6
- diarrhoea6
- international normalised ratio increased6
- pelvic fluid collection6
- pulmonary embolism6
- dyspnoea5
- sepsis5
- vomiting5
- atrial fibrillation4
- infusion site pain4
- malaise4
- pneumonia4
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2007 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 10 |
| 2018 | 3 |
| 2019 | 10 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,099 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pelvic fluid collectionSignal | 6 | 3012.0 | 1404.8 | 15,046 |
| infusion site painSignal | 4 | 108.8 | 42.2 | 326 |
| hypokalaemiaSignal | 10 | 76.0 | 43.1 | 668 |
| international normalised ratio increasedSignal | 6 | 73.8 | 34.5 | 361 |
| pulmonary embolismSignal | 6 | 22.1 | 10.4 | 101 |
| acute kidney injurySignal | 9 | 20.6 | 11.3 | 150 |
| dehydrationSignal | 7 | 18.4 | 9.2 | 99 |
| sepsisSignal | 5 | 15.7 | 6.8 | 55 |
| atrial fibrillationSignal | 4 | 14.4 | 5.6 | 38 |
| pneumoniaSignal | 4 | 4.3 | 1.7 | 7 |
| vomitingSignal | 5 | 3.7 | 1.6 | 8 |
| diarrhoeaSignal | 6 | 3.3 | 1.5 | 7 |
| malaiseSignal | 4 | 3.2 | 1.2 | 4 |
| dyspnoeaSignal | 5 | 3.1 | 1.3 | 5 |
| crohn^s disease | 6 | 0.0 | 0.0 | 1,769,129 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.